Short answer: Ozempic, Wegovy, and Rybelsus are semaglutide brand names. They contain the same active drug, but they do not have the same FDA-approved uses, form, dose schedule, or instructions. Wegovy is semaglutide—not tirzepatide. Zepbound and Mounjaro are brand names for tirzepatide.
Semaglutide is a GLP-1 medication. GLP-1 stands for glucagon-like peptide-1. It can improve blood sugar control and reduce appetite. Knowing the active ingredient is only the first step. The brand tells you which product was studied, how it is given, and what it is approved to treat.
Semaglutide brand names at a glance
| Brand | Active drug | Form | Main approved use |
|---|---|---|---|
| Ozempic | Semaglutide | Injection and product-specific oral tablets | Type 2 diabetes, with additional labeled risk-reduction uses in certain adults |
| Wegovy | Semaglutide | Weekly injection | Chronic weight management and certain labeled risk-reduction uses |
| Rybelsus | Semaglutide | Daily tablet | Type 2 diabetes, with additional labeled risk-reduction use in certain adults |
| Mounjaro | Tirzepatide | Weekly injection | Type 2 diabetes |
| Zepbound | Tirzepatide | Weekly injection | Chronic weight management and another labeled obesity-related use in eligible adults |
FDA approvals can expand over time. The prescribing information for the exact product is the best source for its current uses, warnings, and directions.
What is Ozempic?
Ozempic is best known as a type 2 diabetes medicine. Current FDA records include injectable and product-specific oral forms. Its label also includes risk-reduction uses for some adults with type 2 diabetes and related heart or kidney disease. The exact form and directions on the prescription matter.
Ozempic is not the brand approved specifically for chronic weight management. A clinician may sometimes prescribe a drug for an off-label use, but that is a medical decision. Patients should not assume every prescription is interchangeable.
What is Wegovy?
Wegovy is the main brand of semaglutide for weight loss. It is approved for chronic weight management in adults with obesity or certain adults with overweight and a related health condition. It is used with reduced-calorie nutrition and increased physical activity. Its label also includes cardiovascular risk reduction for certain adults.
As an injectable semaglutide product, Wegovy is used once weekly. Patients should follow the instructions for their exact prescription rather than relying on an old online dosing chart.
Wegovy is not tirzepatide. That common search question has a simple answer: Wegovy contains semaglutide; Zepbound contains tirzepatide.
What is Rybelsus?
Rybelsus is a tablet used for type 2 diabetes. It is taken on an empty stomach with a limited amount of plain water, followed by a waiting period before food, drinks, or other oral medicines. Food, water, and timing can affect absorption, so patients should follow the current product directions.
Rybelsus should not be treated as an oral copy of an injectable dose. The route, strengths, and instructions are different. Follow the current label and prescription rather than converting doses from another semaglutide brand.
Ozempic vs. Wegovy: why the prescription matters
These three brands all use the same active drug, but each has a separate FDA application and label. They can differ in:
- Approved medical use
- Injection versus tablet form
- Available strengths
- Dose-increase schedule
- Device or administration instructions
- Insurance coverage rules
- Clinical evidence for a specific patient group
Using the wrong pen, directions, or dose plan can cause side effects or poor treatment. Never combine semaglutide products unless the prescriber has given a specific, medically reviewed plan.
Semaglutide vs. tirzepatide
The first drug acts on the GLP-1 pathway. The second acts on GLP-1 and GIP. Both can reduce appetite and support weight loss, but they are different medicines. Their doses cannot be converted by matching the number of milligrams.
Ozempic and Rybelsus have diabetes-focused labels. Wegovy has a weight-management label and other approved uses. Mounjaro and Zepbound are tirzepatide brand names. Mounjaro has a diabetes-focused label, while Zepbound has weight-management and other obesity-related uses.
Our semaglutide vs. tirzepatide guide explains the practical differences without treating one drug as automatically “better.”
What does off-label use mean?
Off-label use means an FDA-approved medication is prescribed for a use, patient group, or approach not listed in that product’s approved labeling. Clinicians can prescribe medications off label when they judge it medically appropriate. Off-label does not mean illegal or untested, but it does mean the exact use is not the product’s FDA-approved indication.
Patients should know the active drug, brand, approved use, and reason for the choice. They should also know whether an insurance plan may deny coverage for an off-label use.
Are compounded products another semaglutide brand?
No. “Compounded semaglutide” is not an FDA-approved brand. It is not a generic Ozempic, Wegovy, or Rybelsus. A compounding pharmacy prepares a medication for an individual prescription under applicable rules. The FDA does not review a compounded drug for safety, effectiveness, or quality before it reaches patients.
The FDA has warned about dosing errors, fraudulent products, and some salt forms that differ from the active drug in approved products. Patients should confirm the pharmacy, concentration, measuring units, storage, and exact ingredient.
Do not buy a product sold without a prescription or labeled “for research use only.” If a package, vial, or instruction sheet does not match the prescription, contact the clinic before using it.
Common side effects
Nausea, vomiting, diarrhea, constipation, stomach pain, and reduced appetite are common. Side effects may be more noticeable when starting or increasing the dose. Gradual dose increases are used to improve tolerance, but the exact schedule depends on the product.
Severe or ongoing stomach pain, repeated vomiting, dehydration, symptoms of gallbladder disease, a serious allergic reaction, or sudden vision changes need prompt medical review. Low blood sugar is more likely when semaglutide is combined with insulin or certain diabetes drugs.
Important label warnings
These labels include a boxed warning about thyroid C-cell tumors seen in rodents. It is not known if the drug causes these tumors in people. The products should not be used by patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, also called MEN 2.
Patients should also discuss pregnancy plans, pancreatitis, gallbladder disease, kidney problems, severe digestive disease, diabetes-related eye problems, and upcoming surgery or deep sedation. Product-specific warnings should guide the final decision.
How a provider chooses the right option
The decision begins with the treatment goal. A person seeking diabetes care, cardiovascular risk reduction, or chronic weight management may qualify under different labels. The provider then reviews medical history, current medicines, past response, side effects, cost, coverage, and preference for a tablet or injection.
A structured medical weight-loss program should also address nutrition, activity, sleep, muscle preservation, and follow-up. The brand name matters, but the quality of the full care plan matters more.
Frequently asked questions
Is Wegovy semaglutide or tirzepatide?
Wegovy is semaglutide. Zepbound is tirzepatide.
Are Ozempic and Wegovy the same drug?
They share an active drug, but they are separate FDA-approved products with different labels, strengths, and treatment plans. They should not be swapped without a new prescription.
Rybelsus vs. Ozempic: are they the same pill?
They share an active drug, but Rybelsus and Ozempic have product-specific strengths, labels, and directions. They are not dose-for-dose substitutes.
Which semaglutide brand is approved for weight loss?
In everyday terms, Wegovy is the semaglutide brand approved for weight loss in eligible patients. Its formal label is for chronic weight management and includes clear eligibility rules. The best fit still depends on medical history, availability, insurance coverage, side effects, and the current FDA label.
Can I use two of these brands together?
Do not combine them unless a qualified prescriber has given clear instructions. Duplicate therapy can increase risk and is not a shortcut to faster results.
This article is for general education and does not replace individual medical advice. Brand indications, formulations, and warnings can change. Follow the current prescribing information for the exact product. Compounded drugs are not FDA-approved.
